Danilo Faccenda

1.2k total citations
20 papers, 731 citations indexed

About

Danilo Faccenda is a scholar working on Molecular Biology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Danilo Faccenda has authored 20 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Danilo Faccenda's work include ATP Synthase and ATPases Research (9 papers), Mitochondrial Function and Pathology (7 papers) and Cardiac pacing and defibrillation studies (3 papers). Danilo Faccenda is often cited by papers focused on ATP Synthase and ATPases Research (9 papers), Mitochondrial Function and Pathology (7 papers) and Cardiac pacing and defibrillation studies (3 papers). Danilo Faccenda collaborates with scholars based in United Kingdom, Italy and Germany. Danilo Faccenda's co-authors include Michelangelo Campanella, Aarti Singh, Mauro Piacentini, Stefano Bartesaghi, Andrew W. McEvoy, Michael R. Duchen, S. Sanzone, Fabrizio Condorelli, Richard Grose and M. Shaked-Rabi and has published in prestigious journals such as Oncogene, The FASEB Journal and Cell Death and Differentiation.

In The Last Decade

Danilo Faccenda

17 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danilo Faccenda United Kingdom 12 568 220 162 100 74 20 731
Jacqueline Tait-Mulder United Kingdom 10 851 1.5× 350 1.6× 192 1.2× 122 1.2× 107 1.4× 12 1.1k
Soung Jung Kim South Korea 14 400 0.7× 116 0.5× 104 0.6× 49 0.5× 78 1.1× 16 637
Matteo Giovarelli Italy 18 628 1.1× 126 0.6× 283 1.7× 60 0.6× 138 1.9× 31 907
Mohamed A. Eldeeb Canada 16 489 0.9× 234 1.1× 48 0.3× 97 1.0× 77 1.0× 45 750
Justine Lebeau France 10 536 0.9× 200 0.9× 66 0.4× 319 3.2× 64 0.9× 11 772
Lauren E. Drake United States 8 579 1.0× 516 2.3× 215 1.3× 149 1.5× 59 0.8× 9 904
Marion Bergmann Germany 11 502 0.9× 142 0.6× 56 0.3× 68 0.7× 47 0.6× 17 791
Ana Serrano‐Puebla Spain 7 390 0.7× 332 1.5× 35 0.2× 72 0.7× 70 0.9× 7 699
Zhengquan Yu China 10 416 0.7× 118 0.5× 141 0.9× 62 0.6× 55 0.7× 25 678
Toby A. Dite Australia 14 643 1.1× 199 0.9× 86 0.5× 61 0.6× 87 1.2× 24 809

Countries citing papers authored by Danilo Faccenda

Since Specialization
Citations

This map shows the geographic impact of Danilo Faccenda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Faccenda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Faccenda more than expected).

Fields of papers citing papers by Danilo Faccenda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danilo Faccenda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Faccenda. The network helps show where Danilo Faccenda may publish in the future.

Co-authorship network of co-authors of Danilo Faccenda

This figure shows the co-authorship network connecting the top 25 collaborators of Danilo Faccenda. A scholar is included among the top collaborators of Danilo Faccenda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danilo Faccenda. Danilo Faccenda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faccenda, Danilo, et al.. (2025). Unravelling the impact of mycotoxins on gut health: implications for inflammatory bowel disease. Current Opinion in Food Science. 64. 101316–101316. 1 indexed citations
2.
Faccenda, Danilo, Vittorio Russo, Ernesto Ammendola, et al.. (2024). Impact of taurolidine use during cardiac electronic implantable device implantation in heart failure patients. EP Europace. 26(Supplement_1).
3.
Faccenda, Danilo, Valeria Pergola, Alessandro Volpe, et al.. (2024). Cardioneuroablation: the known and the unknown. Frontiers in Cardiovascular Medicine. 11. 1412195–1412195.
4.
Faccenda, Danilo, et al.. (2024). A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy. EP Europace. 26(Supplement_1). 1 indexed citations
5.
Reid, Kimberley M., Danilo Faccenda, Bárbara Pernaute, et al.. (2023). MicroRNAs Regulate Ca2+ Homeostasis in Murine Embryonic Stem Cells. Cells. 12(15). 1957–1957.
6.
Faccenda, Danilo, et al.. (2023). Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2. EP Europace. 25(Supplement_1). 1 indexed citations
7.
Singh, Aarti, Danilo Faccenda, & Michelangelo Campanella. (2021). Pharmacological advances in mitochondrial therapy. EBioMedicine. 65. 103244–103244. 77 indexed citations
8.
Faccenda, Danilo, Rosella Abeti, Daniela Strobbe, et al.. (2021). The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity. Molecular Psychiatry. 26(7). 2721–2739. 13 indexed citations
9.
Faccenda, Danilo, Adam Jones, Claire Thornton, et al.. (2020). The ATPase Inhibitory Factor 1 (IF1) regulates the expression of the mitochondrial Ca2+ uniporter (MCU) via the AMPK/CREB pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1868(1). 118860–118860. 12 indexed citations
10.
Strobbe, Daniela, Antonella Minutolo, Christine M. M. Hendriks, et al.. (2020). NH‐sulfoximine: A novel pharmacological inhibitor of the mitochondrial F1Fo‐ATPase, which suppresses viability of cancerous cells. British Journal of Pharmacology. 178(2). 298–311. 11 indexed citations
11.
Faccenda, Danilo, et al.. (2019). Species‐specific consequences of an E40K missense mutation in superoxide dismutase 1 (SOD1). The FASEB Journal. 34(1). 458–473. 3 indexed citations
12.
Faccenda, Danilo, E. Kaitlynn Allen, Caterina Ferraina, et al.. (2018). Reduction of the ATPase inhibitory factor 1 (IF1) leads to visual impairment in vertebrates. Cell Death and Disease. 9(6). 669–669. 16 indexed citations
13.
D’Eletto, Manuela, Federica Rossin, Maria Grazia Farrace, et al.. (2018). Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. Cell Reports. 25(13). 3573–3581.e4. 135 indexed citations
14.
Hawkins, Kate, Dafni Moschidou, Danilo Faccenda, et al.. (2017). Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency. Molecular Therapy. 25(2). 427–442. 7 indexed citations
15.
Faccenda, Danilo, et al.. (2017). Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1. Cell Reports. 18(8). 1869–1883. 63 indexed citations
16.
Ivanés, Fabrice, Danilo Faccenda, Jemma Gatliff, et al.. (2014). The compoundBTB06584 is anIF1‐dependent selective inhibitor of the mitochondrialF1Fo‐ATPase. British Journal of Pharmacology. 171(18). 4193–4206. 26 indexed citations
17.
Faccenda, Danilo, Choon‐Hong Tan, Andreas Seraphim, Michael R. Duchen, & Michelangelo Campanella. (2013). IF1 limits the apoptotic-signalling cascade by preventing mitochondrial remodelling. Cell Death and Differentiation. 20(5). 686–697. 71 indexed citations
18.
Galavotti, Sara, Stefano Bartesaghi, Danilo Faccenda, et al.. (2012). The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene. 32(6). 699–712. 219 indexed citations
19.
Faccenda, Danilo, et al.. (2012). PK11195 Inhibits Mitophagy Targeting the F1Fo-ATPsynthase in Bcl-2 Knock-Down Cells. Current Molecular Medicine. 12(4). 476–482. 25 indexed citations
20.
Faccenda, Danilo & Michelangelo Campanella. (2012). Molecular Regulation of the Mitochondrial F1Fo-ATPsynthase: Physiological and Pathological Significance of the Inhibitory Factor 1 (IF1). International Journal of Cell Biology. 2012. 1–12. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Tait-Mulder Breakdown of academic impact, for papers by Soung Jung Kim Breakdown of academic impact, for papers by Matteo Giovarelli Breakdown of academic impact, for papers by Mohamed A. Eldeeb Breakdown of academic impact, for papers by Justine Lebeau Breakdown of academic impact, for papers by Lauren E. Drake Breakdown of academic impact, for papers by Marion Bergmann Breakdown of academic impact, for papers by Ana Serrano‐Puebla Breakdown of academic impact, for papers by Zhengquan Yu Breakdown of academic impact, for papers by Toby A. Dite
Rankless by CCL
2026